All In MedTech

FDA Clearance Tracker · P150031-S034

Vercise Genus Deep Brain Stimulation (DBS) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 21, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 21, 2021

Approved

Time to decision

273 days

Received Apr 23, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P150031-S034
Device name
Vercise Genus Deep Brain Stimulation (DBS) System
Applicant location
Valencia, CA
Received
Apr 23, 2020
Decided
Jan 21, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P150031

Device type

Device class
Class III

Every decision under product code NHL

FDA's approval statement

As written in FDA's record.

Approval for the Vercise Genus Deep Brain Stimulation (DBS) System.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.